The prevalence of metabolic disorders, including obesity, metabolic syndrome, and type 2 diabetes (T2D), is escalating in Asian countries. Consequently, metabolic dysfunction leading to metabolic syndrome and T2D is expected to account for a majority of the health burden, including cardiovascular diseases, in these countries in the near future. To highlight the latest and most impactful science on this topic, JACC: Asia is inviting high-quality manuscripts addressing all topics related to metabolic disorders in Asian populations. Submissions are due by Dec. 31. Learn more.